Literature DB >> 23664596

Effects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitus.

Robert C Block1, Amir Abdolahi, Brian Smith, N Meednu, Kelly Thevenet-Morrison, Xueya Cai, Huadong Cui, Shaker Mousa, J Thomas Brenna, S Georas.   

Abstract

INTRODUCTION: Many diabetics are insensitive to aspirin's platelet anti-aggregation effects. The possible modulating effects of co-administration of aspirin and fish oil in subjects with diabetes are poorly characterized. PARTICIPANTS AND METHODS: Thirty adults with type 2 diabetes mellitus were treated with aspirin 81 mg/d for 7 days, then with fish oil 4 g/day for 28 days, then the combination of fish oil and aspirin for another 7 days.
RESULTS: Aspirin alone and in combination with fish oil reduced platelet aggregation in most participants. Five of 7 participants classified as aspirin insensitive 1 week after daily aspirin ingestion were sensitive after the combination. Although some platelet aggregation measures correlated positively after aspirin and fish oil ingestion alone and (in combination) in all individuals, correlation was only observed in those who were aspirin insensitive after ingestion of the combination.
CONCLUSIONS: Co-administration of aspirin and fish oil may reduce platelet aggregation more than aspirin alone in adults with diabetes mellitus.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23664596      PMCID: PMC3683095          DOI: 10.1016/j.plefa.2013.03.005

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  50 in total

1.  Resolvin E1 regulates adenosine diphosphate activation of human platelets.

Authors:  Gabrielle Fredman; Thomas E Van Dyke; Charles N Serhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-11       Impact factor: 8.311

2.  Effect of leptin on arterial thrombosis following vascular injury in mice.

Authors:  Peter F Bodary; Randal J Westrick; Kevin J Wickenheiser; Yuechen Shen; Daniel T Eitzman
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

Review 3.  Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease.

Authors:  Marika Massaro; Egeria Scoditti; Maria Annunziata Carluccio; Raffaele De Caterina
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-10-23       Impact factor: 4.006

4.  Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.

Authors:  Paul A Gurbel; Kevin P Bliden; Joseph DiChiara; Justin Newcomer; Willy Weng; Nagaraj K Neerchal; Tania Gesheff; Srivasavi K Chaganti; Amena Etherington; Udaya S Tantry
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

5.  Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects.

Authors:  Mark K Larson; Joseph H Ashmore; Kristina A Harris; Jessica L Vogelaar; James V Pottala; Michael Sprehe; William S Harris
Journal:  Thromb Haemost       Date:  2008-10       Impact factor: 5.249

Review 6.  Safety considerations with omega-3 fatty acid therapy.

Authors:  Harold E Bays
Journal:  Am J Cardiol       Date:  2006-11-28       Impact factor: 2.778

7.  Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease.

Authors:  Pauline D Watson; Parijat S Joy; Chileshe Nkonde; Scott E Hessen; Dean G Karalis
Journal:  Am J Cardiol       Date:  2009-08-25       Impact factor: 2.778

8.  The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort.

Authors:  Paul Holvoet; Stephen B Kritchevsky; Russell P Tracy; Ann Mertens; Susan M Rubin; Javed Butler; Bret Goodpaster; Tamara B Harris
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

Review 9.  The inhibition of endothelial activation by unsaturated fatty acids.

Authors:  R De Caterina; M Spiecker; G Solaini; G Basta; F Bosetti; P Libby; J Liao
Journal:  Lipids       Date:  1999       Impact factor: 1.646

10.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

View more
  9 in total

1.  The effects of aspirin and N-3 fatty acids on telomerase activity in adults with diabetes mellitus.

Authors:  Ashley Holub; Shaker Mousa; Amir Abdolahi; Kavitha Godugu; Xin M Tu; J Thomas Brenna; Robert C Block
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-06-25       Impact factor: 4.222

2.  The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA.

Authors:  Robert C Block; Amir Abdolahi; Xin Tu; Steve N Georas; J Thomas Brenna; Richard P Phipps; Peter Lawrence; Shaker A Mousa
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-12-22       Impact factor: 4.006

3.  Increases in ambient particulate matter air pollution, acute changes in platelet function, and effect modification by aspirin and omega-3 fatty acids: A panel study.

Authors:  Adan Z Becerra; Steve Georas; J Thomas Brenna; Philip K Hopke; Cathleen Kane; David Chalupa; Mark W Frampton; Robert Block; David Q Rich
Journal:  J Toxicol Environ Health A       Date:  2016-03-30

4.  The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus.

Authors:  Amir Abdolahi; Steve N Georas; J Thomas Brenna; Xueya Cai; Kelly Thevenet-Morrison; Richard P Phipps; Peter Lawrence; Shaker A Mousa; Robert C Block
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-12-18       Impact factor: 4.006

5.  Novel venous thromboembolic disease (VTED) prophylaxis for total knee arthroplasty-aspirin and fish oil.

Authors:  Peter M Bonutti; Nipun Sodhi; Yatindra H Patel; Assem A Sultan; Anton Khlopas; Morad Chughtai; Frank R Kolisek; Nick Williams; Michael A Mont
Journal:  Ann Transl Med       Date:  2017-12

6.  Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus.

Authors:  Robert C Block; Ashley Holub; Amir Abdolahi; Xin M Tu; Shaker A Mousa; Michael N Oda
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-09-09       Impact factor: 4.006

7.  Aspirin and omega-3 fatty acid status interact in the prevention of cardiovascular diseases in Framingham Heart Study.

Authors:  Robert C Block; Gregory C Shearer; Ashley Holub; Xin M Tu; Shaker Mousa; J Thomas Brenna; William S Harris; Nathan Tintle
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-04-24       Impact factor: 3.015

8.  Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece.

Authors:  Marios Spanakis; Maria Melissourgaki; George Lazopoulos; Athina E Patelarou; Evridiki Patelarou
Journal:  Pharmaceutics       Date:  2021-02-09       Impact factor: 6.321

9.  Do elevated blood levels of omega-3 fatty acids modify effects of particulate air pollutants on fibrinogen?

Authors:  Daniel Croft; Robert Block; Scott J Cameron; Kristin Evans; Charles J Lowenstein; Frederick Ling; Wojciech Zareba; Philip K Hopke; Mark J Utell; Sally W Thurston; Kelly Thevenet-Morrison; David Q Rich
Journal:  Air Qual Atmos Health       Date:  2018-06-03       Impact factor: 3.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.